<DOC>
	<DOCNO>NCT01299467</DOCNO>
	<brief_summary>The purpose study find long effect PF-03526299 last inhale assess lung function mild asthma patient expose allergen</brief_summary>
	<brief_title>A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge</brief_title>
	<detailed_description>To assess duration action compound suppress early late allergen response asthma patient</detailed_description>
	<criteria>Male and/or female subject age 18 60 year , inclusive . A history diagnosis asthma require use beta 2 agonist bronchodilator ( eg Salbutamol ) . Women could become pregnant must use appropriate birth control throughout study pregnancy test must negative entering study prior dose clinic . Subjects hospitalized treatment asthma within three month prior study entry , hospitalize twice last 12 month . Subjects experience low respiratory tract infection ( eg bronchitis pneumonia ) significant asthma instability 4 week prior study entry . Severe additional disease asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>duration action</keyword>
	<keyword>allergen challenge</keyword>
</DOC>